Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285729280> ?p ?o ?g. }
- W4285729280 endingPage "3353" @default.
- W4285729280 startingPage "3345" @default.
- W4285729280 abstract "In patients with systemic lupus erythematosus (SLE), a higher frequency of atherosclerotic lesions is associated with poor prognosis. Hydroxychloroquine (HCQ) has been reported to improve the lifespan and the prognosis of dyslipidaemia in patients with SLE, but the mechanism is unclear. We investigated the effect of supplemental HCQ treatment on the levels of serum cytokines associated with atherosclerosis in patients with stable SLE.Patients with SLE who received supplemental HCQ and maintained low disease activity between January 2016 and September 2020 were included in this study. Disease activity was assessed using Safety of Estrogens in Lupus National Assessment-SLE Disease Activity Index, Cutaneous Lupus Erythematous Disease Area and Severity Index, and Lupus Low Disease Activity State. Serum complement titres, anti-dsDNA antibodies, and serum cytokines (adiponectin, resistin, and leptin) were analyzed before and after HCQ treatment.Forty-one patients (4 males and 37 females, mean age 41.3 ± 13.2 years) were included. Serum adiponectin levels were significantly increased after 3 months of HCQ treatment compared to baseline, and serum resistin levels were significantly reduced. The change in serum resistin level after HCQ administration was correlated with a significant reduction in serum TNF-α, interleukin (IL)-6, IL-8, and IL-1RA levels.Supplemental HCQ treatment in patients with SLE improved adipokine levels. HCQ may improve prognosis by controlling disease activity in SLE and reducing risk factors for atherosclerosis. Key Points • Hydroxychloroquine has been reported to improve the prognosis of dyslipidaemia in patients with SLE, but the underlying mechanism is unclear. • In this study, hydroxychloroquine improved adipokine levels in patients with SLE, implicating adipokines as a potential mechanism underlying the benefit of hydroxychloroquine on dyslipidaemia. • Supplemental hydroxychloroquine should be considered in patients with SLE harboring lipid abnormalities and risk factors for atherosclerosis." @default.
- W4285729280 created "2022-07-18" @default.
- W4285729280 creator A5007124268 @default.
- W4285729280 creator A5014406593 @default.
- W4285729280 creator A5015635405 @default.
- W4285729280 creator A5019020114 @default.
- W4285729280 creator A5020106035 @default.
- W4285729280 creator A5025343523 @default.
- W4285729280 creator A5039687984 @default.
- W4285729280 creator A5042692146 @default.
- W4285729280 creator A5045326861 @default.
- W4285729280 creator A5071465896 @default.
- W4285729280 creator A5073248245 @default.
- W4285729280 creator A5075626153 @default.
- W4285729280 creator A5086235674 @default.
- W4285729280 date "2022-07-18" @default.
- W4285729280 modified "2023-10-18" @default.
- W4285729280 title "Supplemental hydroxychloroquine therapy regulates adipokines in patients with systemic lupus erythematosus with stable disease" @default.
- W4285729280 cites W1519908611 @default.
- W4285729280 cites W1903248918 @default.
- W4285729280 cites W1978758952 @default.
- W4285729280 cites W1989924681 @default.
- W4285729280 cites W2014873778 @default.
- W4285729280 cites W2035915584 @default.
- W4285729280 cites W2047342378 @default.
- W4285729280 cites W2049378381 @default.
- W4285729280 cites W2055766443 @default.
- W4285729280 cites W2081819242 @default.
- W4285729280 cites W2119837784 @default.
- W4285729280 cites W2137168534 @default.
- W4285729280 cites W2141455950 @default.
- W4285729280 cites W2148722507 @default.
- W4285729280 cites W2154383959 @default.
- W4285729280 cites W2158927265 @default.
- W4285729280 cites W2159860161 @default.
- W4285729280 cites W2199189793 @default.
- W4285729280 cites W2255510115 @default.
- W4285729280 cites W2432984718 @default.
- W4285729280 cites W2472237827 @default.
- W4285729280 cites W2499140734 @default.
- W4285729280 cites W2747810375 @default.
- W4285729280 cites W2750879036 @default.
- W4285729280 cites W2754406772 @default.
- W4285729280 cites W2757575073 @default.
- W4285729280 cites W2759047915 @default.
- W4285729280 cites W2766897198 @default.
- W4285729280 cites W2886644509 @default.
- W4285729280 cites W2901509748 @default.
- W4285729280 cites W2909131229 @default.
- W4285729280 cites W2921267031 @default.
- W4285729280 cites W2927871970 @default.
- W4285729280 cites W2948305103 @default.
- W4285729280 cites W2953916091 @default.
- W4285729280 cites W2958502619 @default.
- W4285729280 cites W3004709581 @default.
- W4285729280 cites W3014721173 @default.
- W4285729280 cites W3092298866 @default.
- W4285729280 cites W3095697336 @default.
- W4285729280 cites W3110711326 @default.
- W4285729280 cites W3129101512 @default.
- W4285729280 cites W960848000 @default.
- W4285729280 doi "https://doi.org/10.1007/s10067-022-06282-0" @default.
- W4285729280 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35849246" @default.
- W4285729280 hasPublicationYear "2022" @default.
- W4285729280 type Work @default.
- W4285729280 citedByCount "1" @default.
- W4285729280 countsByYear W42857292802023 @default.
- W4285729280 crossrefType "journal-article" @default.
- W4285729280 hasAuthorship W4285729280A5007124268 @default.
- W4285729280 hasAuthorship W4285729280A5014406593 @default.
- W4285729280 hasAuthorship W4285729280A5015635405 @default.
- W4285729280 hasAuthorship W4285729280A5019020114 @default.
- W4285729280 hasAuthorship W4285729280A5020106035 @default.
- W4285729280 hasAuthorship W4285729280A5025343523 @default.
- W4285729280 hasAuthorship W4285729280A5039687984 @default.
- W4285729280 hasAuthorship W4285729280A5042692146 @default.
- W4285729280 hasAuthorship W4285729280A5045326861 @default.
- W4285729280 hasAuthorship W4285729280A5071465896 @default.
- W4285729280 hasAuthorship W4285729280A5073248245 @default.
- W4285729280 hasAuthorship W4285729280A5075626153 @default.
- W4285729280 hasAuthorship W4285729280A5086235674 @default.
- W4285729280 hasBestOaLocation W42857292802 @default.
- W4285729280 hasConcept C126322002 @default.
- W4285729280 hasConcept C134018914 @default.
- W4285729280 hasConcept C159654299 @default.
- W4285729280 hasConcept C194832188 @default.
- W4285729280 hasConcept C198451711 @default.
- W4285729280 hasConcept C203014093 @default.
- W4285729280 hasConcept C2775915377 @default.
- W4285729280 hasConcept C2776782570 @default.
- W4285729280 hasConcept C2776912625 @default.
- W4285729280 hasConcept C2777391703 @default.
- W4285729280 hasConcept C2779123688 @default.
- W4285729280 hasConcept C2779134260 @default.
- W4285729280 hasConcept C2779760629 @default.
- W4285729280 hasConcept C2780613262 @default.
- W4285729280 hasConcept C3008058167 @default.
- W4285729280 hasConcept C511355011 @default.